{"nct_id":"NCT02046070","title":"Phase 2 Study to Evaluate the Oral Combination of Ixazomib (MLN9708) With Cyclophosphamide and Dexamethasone in Patients With Newly Diagnosed or Relapsed and/or Refractory Multiple Myeloma","status":"COMPLETED","status_verified_date":"2019-06","start_date":"2014-03-05","start_date_type":"ACTUAL","primary_completion_date":"2018-06-29","primary_completion_date_type":"ACTUAL","completion_date":"2018-06-29","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["TAK"]}